Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Gastrointestinal 1 Breast 1

Conditions

Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms 1

Interventions

Fulvestrant 82 Letrozole 75 Paclitaxel 71 pembrolizumab 67 Specimen Handling 63 Trastuzumab 61 Carboplatin 56 Magnetic Resonance Spectroscopy 50 ribociclib 47 Capecitabine 47 Anastrozole 46 pertuzumab 45 palbociclib 44 exemestane 38 Tamoxifen 38 Cyclophosphamide 38 abemaciclib 37 Biopsy 36 trastuzumab deruxtecan 30 Docetaxel 29 Taxes 27 Gemcitabine 25 Radiotherapy 24 Surveys and Questionnaires 23 130-nm albumin-bound paclitaxel 23 Blood Specimen Collection 22 Standard of Care 21 sacituzumab govitecan 20 olaparib 20 eribulin 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

FAPI-46 × Breast × 90 days × Clear all

NCT06540872 2026-06-03

MI-CISDIR

Universität Münster

Phase 2 Recruiting

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡